NCT07213986 is a NA clinical trial of Vibrant Capsule in Neurogenic Bowel Dysfunction, sponsored by The University of Texas Health Science Center, Houston.

Who is sponsoring NCT07213986?

NCT07213986 is sponsored by The University of Texas Health Science Center, Houston.

What drugs are being tested in NCT07213986?

Interventions in NCT07213986: Vibrant Capsule.

What condition does NCT07213986 study?

NCT07213986 studies Neurogenic Bowel Dysfunction, Spinal Cord Injury.

Is NCT07213986 still recruiting?

NCT07213986 is currently recruiting now. Last updated 14 January 2026.

Last reviewed 2026-01-14 · How we verify

NCT07213986

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Vibrant Capsule for Spinal Cord Injury Neurogenic Bowel Dysfunction

Recruiting now NA Last updated 14 January 2026

What this trial tests

NA trial testing Vibrant Capsule in Neurogenic Bowel Dysfunction in 12 participants. Currently enrolling.

Timeline

6 January 2026

Primary endpoint
1 March 2026

1 March 2026

Quick facts

Lead sponsor	The University of Texas Health Science Center, Houston
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	12
Start date	6 January 2026
Primary completion	1 March 2026
Estimated completion	1 March 2026
Sites	1 location across United States

Drugs / interventions tested

Vibrant Capsule

Conditions studied

Neurogenic Bowel Dysfunction — all drugs for Neurogenic Bowel Dysfunction →
Spinal Cord Injury — all drugs for Spinal Cord Injury →

Sponsor

The University of Texas Health Science Center, Houston

Who can join

21 and older, any sex, with Neurogenic Bowel Dysfunction or Spinal Cord Injury. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this study is to test the safety and effectiveness of Vibrant capsules in spinal cord injury patients with neurogenic bowel.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Neurogenic Bowel Dysfunction

Currently open trials in the same condition.

NCT06078176 — Stimulation for Bowel Emptying · NA · recruiting

Other The University of Texas Health Science Center, Houston trials

Trials by the same sponsor.

NCT04200729 — Povidone-iodine Irrigation for Prevention of Intra-abdominal Abscess in Pediatric Perforated Appendicitis: a Multi-cente · Phase 4 · not yet recruiting
NCT07225062 — Improving HIV Prevention and Substance Use Post-Sexual Assault Services · NA · not yet recruiting
NCT07396974 — Increasing Treatment Access in Trauma Exposed Children: Developing an Adapted Step One Intervention (RCT) · NA · not yet recruiting
NCT07170163 — Navigating the Transition to Adulthood: A Dual Language Mobile App for Latino Youth With ASD and Their Families · NA · not yet recruiting
NCT06915441 — Lipid Infusions to Optimize Nutrition Trial · Phase 2 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07213986 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by The University of Texas Health Science Center, Houston
Last refreshed: 14 January 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07213986.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing